Final Program

204 MONDAY • MAY 16
WS3
CLINICAL
WORKSHOP
CME Credits Available: 1.5
Nursing Contact Hours Available: 1.8
PULMONARY REHABILITATION FOR INTERSTITIAL
LUNG DISEASE: OPTIMIZING THE MODEL
Registration Fee: $75.00 (includes box lunch)
Attendance is limited. Pre-registration is required.
Assemblies on Pulmonary Rehabilitation; Clinical Problems; Nursing
11:45 a.m. - 1:15 p.m. MOSCONE CENTER
Room 301 (South Building, Esplanade Level)
Target Audience
Providers of care to people with interstitial lung disease; providers of
pulmonary rehabilitation.
Objectives
At the conclusion of this session, the participant will be able to:
• learn about the state of the science underpinning ILD rehabilitation;
• prescribe effective exercise training for people with ILD;
• gain new strategies for comprehensive rehabilitation in ILD.
This workshop will define the state of the evidence for pulmonary rehabilitation
in interstitial lung disease (ILD) and explore strategies to optimize rehabilitation
outcomes for patients with these diverse and disabling respiratory conditions.
Chairing: A.E. Holland, PhD, Melbourne, Australia
L.P. Cahalin, PhD, Miami, FL
11:45 Rehabilitation for ILD: State of the Evidence
A.E. Holland, PhD, Melbourne, Australia
12:00 Peripheral Muscle in ILD: Does it Matter?
S. Mathur, PhD, PT, Toronto, Canada
12:15 Exercise Training Strategies for ILD: Meeting the Physiological
Challenge
B. Vainshelboim, PhD, Petach Tikva, Israel
12:35 Beyond Exercise Training: What is Comprehensive
Rehabilitation for ILD?
J.J. Swigris, DO, MS, Denver, CO
12:55 Capturing Important Changes: Measurement of Outcomes in
Rehabilitation for ILD
L. Dowman, MAppSc, Heidelberg, Australia
WS4
BASIC • CLINICAL • TRANSLATIONAL
WORKSHOP
CME Credits Available: 1.5
PATIENT-DERIVED MODELS OF HUMAN LUNG
DISEASE: A LAB MEETING
Registration Fee: $75.00 (includes box lunch)
Attendance is limited. Pre-registration is required.
Assemblies on Respiratory Cell and Molecular Biology; Allergy,
Immunology and Inflammation; Clinical Problems; Critical Care;
Environmental, Occupational and Population Health; Microbiology,
Tuberculosis and Pulmonary Infections; Pediatrics; Pulmonary
Circulation; Pulmonary Rehabilitation; Respiratory Structure and
Function; Sleep and Respiratory Neurobiology; Thoracic Oncology
11:45 a.m. - 1:15 p.m. MOSCONE CENTER
Room 302 (South Building, Esplanade Level)
Target Audience
Lung health care providers, scientists and investigators interested or involved
in basic, translational and clinical research related to the pathogenesis,
pathology and clinical aspects of COPD and related human lung diseases,
research and care providers engaged in pulmonary and critical care medicine.
Objectives
At the conclusion of this session, the participant will be able to:
• learn about state of the art in vivo, ex vivo and in vitro patient-derived
models of human lung biology and disease;
• implement patient-derived models to study the pathogenesis, phenotype
and candidate therapies for human lung diseases;
• understand how to translate information derived from patient-derived
models into innovative clinically relevant approaches to study, diagnose,
prevent and treat human lung diseases in a personalized manner
(“precision medicine”).
This workshop will discuss state of the art methods to study chronic human lung
diseases (asthma, cystic fibrosis, COPD, and pulmonary fibrosis) in a
personalized manner by modeling complex interaction between different cell
types and tissue components (epithelial cells, extracellular matrix, fibroblasts,
blood vessels, immune cells etc) using patient-derived human samples. In
addition to talks by leading experts in the field, during this session, participants
will have an opportunity to discuss their own research problems, ideas and
questions with the faculty in a “lab meeting format” and learn how to translate
discoveries derived from studies using patient-derived models into novel
personalized approaches to prevent and treat human lung diseases (targeted
“precision medicine” strategies).
Chairing: R. Shaykhiev, MD, PhD, New York, NY
S.D. Reynolds, PhD, Columbus, OH
D.J. Weiss, MD, PhD, Burlington, VT
11:45 “Personalized” In Vitro and Ex Vivo Models of Human Airway
Disease
S.H. Randell, PhD, Chapel Hill, NC
12:00 Patient-Derived 3D-Models of COPD and Emphysema
M. Konigshoff, MD, PhD, Munich, Germany
12:15 Preclinical Humanized Models of Airway Remodeling in
Asthma
R. Freishtat, MD, MPH, Washington, DC
12:30 Modeling Lung Disease Using iPS Cells: Towards Precision
Medicine
D.N. Kotton, MD, Boston, MA
12:45 “Lab Meeting” Discussion
Z. Borok, MD, Los Angeles, CA
C. Coraux, PhD, Reims, France
ATS 2016 • San Francisco